Shah Shares Immunotherapy, STAT3 Inhibitor Data in GI Cancers
Categories
Two clinical trials presented at the 2018 ASCO Annual Meeting addressed unmet needs for select with patients with gastrointestinal (GI) cancers; however, a number of challenges remain, explained Manish A. Shah, MD.
https://www.onclive.com/web-exclusives/shah-shares-immunotherapy-stat3-inhibitor-data-in-gi-cancers